SAN DIEGO, CA / ACCESS Newswire / March 30, 2025 / Robbins LLP reminds stockholders that a class action was filed on behalf ...
ShORe Phase 3 topline results accelerated; trial did not meet primary endpoint of mean change in BCVA from baseline to week 52Opthea and DFA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback